2,3,7,8-Tetrachlorodibenzo-p-dioxin
SmallMolecule
T3DB_ID
T3D0073
描述
2,3,7,8-Tetrachlorodibenzo-p-dioxin is the most toxic of 75 chlorinated dibenzo-p-dioxin (CDD) congeners. CDDs are a class of manufactured chemicals that consist of dioxin skeletel structures with chlorine substituents. They are also persistent organic pollutants (POPs), thus their production is regulated in most areas. Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)
类别
"Industrial/Workplace Toxin", "Pollutant", "Airborne Pollutant", "Synthetic Toxin"
同义词
"2,3,6,7-Tetrachlorodibenzo-p-dioxin", "2,3,7,8-:tetrachlorodibenzo-p-dioxin", "2,3,7,8-Tetra polychlorinated dibenzo-p-dioxin", "2,3,7,8-Tetrachloro(b,e)dibenzodioxin", "2,3,7,8-Tetrachloro(b,f)dibenzodioxin", "2,3,7,8-Tetrachlorodibenzo(b,e)(1,4)dioxan", "2,3,7,8-Tetrachlorodibenzo(b,e)(1,4)dioxin", "2,3,7,8-Tetrachlorodibenzo-1,4-Dioxin", "2,3,7,8-Tetrachlorodibenzo-P-dioxin", "2,3,7,8-tetrachlorodibenzodioxin", "2,3,7,8-tetrachlorodibenzodioxine", "2,3,7,8-Tetrachlorodibenzo[b,e][1,4]dioxin", "2,3,7,8-Tetrachlorooxanthrene", "Dibenzo-dioxin, 2,3,7,8-tetrachlorinated", "Tetrachlorodibenzo-1,4-dioxin", "Tetrachlorodibenzo-p-dioxin", "Tetrachlorodibenzodioxin", "Tetradioxin"
CAS登记号
1746-01-6
化学式
C12H4Cl4O2
平均分子量
321.971
单同位素质量
319.8965402
IUPAC 名称
2,3,7,8-tetrachlorooxanthrene
传统名称
dioxin
简化分子线性输入规范
ClC1=CC2=C(OC3=C(O2)C=C(Cl)C(Cl)=C3)C=C1Cl
InChI 标识符
InChI=1S/C12H4Cl4O2/c13-5-1-9-10(2-6(5)14)18-12-4-8(16)7(15)3-11(12)17-9/h1-4H
InChIKey=HGUFODBRKLSHSI-UHFFFAOYSA-N
化合物类型
Organic compounds
大分类
Organoheterocyclic compounds
类型
Benzodioxins
子类
Benzo-p-dioxins
直接大类
Chlorinated dibenzo-p-dioxins
另外分类
"Aryl chlorides", "Benzenoids", "Diarylethers", "Hydrocarbon derivatives", "Organochlorides", "Oxacyclic compounds"
取代基
"Aromatic heteropolycyclic compound", "Aryl chloride", "Aryl halide", "Benzenoid", "Chlorinated-dibenzo-p-dioxin", "Diaryl ether", "Ether", "Hydrocarbon derivative", "Organic oxygen compound", "Organochloride", "Organohalogen compound", "Organooxygen compound", "Oxacycle"
分子框架
Aromatic heteropolycyclic compounds
外部描述符
"PCDDs", "polychlorinated dibenzodioxine"
地位
Detected and Not Quantified
起源
Exogenous
蜂窝位置
"Actin Filament", "Basolateral Membrane", "Cell junction", "Cell surface", "Centrosome", "Cytosol", "Extracellular", "Extracellular matrix", "Focal adhesion", "Lysosome", "Membrane", "Membrane Fraction", "Microsome", "Microtubule", "Mitochondrion", "Nuclear Matrix", "Nuclear Membrane", "Nucleolus", "Peroxisome", "Plasma Membrane", "Sarcoplasmic Reticulum", "Secretory Granule", "Tubulin"
生物流体位置
组织位置
途径
"Apoptosis", "Cell cycle", "Insulin secretion", "Arachidonic Acid Metabolism", "Wnt signaling pathway", "Fatty acid Metabolism", "Ovarian Steroidogenesis", "Insulin signaling pathway", "Proteasome", "Eicosanoids", "Rna polymerase", "Phenothiazines", "Oxidative phosphorylation", "Nitrogen Metabolism", "Long-term potentiation", "Inositol Phosphate Metabolism", "Endocytosis", "Circadian rhythm", "Axon guidance"
状态
Solid
外貌
Colorless solid.
熔点/沸点/溶解度
305°C//2e-07 mg/mL at 25 °C [SHIU,WY et al. (1988)]
日志P
暴露途径
Oral (L177) ; inhalation (L177) ; dermal (L177)
毒性机制
CDDs bind to the aryl hydrocarbon (Ah) receptor and subsequently alter the transcription of several genes (oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes). The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. 2,3,7,8-tetrachlorodibenzo-p-dioxin's carcinogenicity is thought to be the result of its ability to alter the capacity of both exogenous and endogenous substances to damage the DNA by inducing CYP1A1- and CYP1A2-dependent drug-metabolizing enzymes. (L177)
代谢
CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, and mainly distributed in the liver and adipose tissue. CDDs are slowly metabolized to polar metabolites by the microsomal monooxygenase system. These metabolites can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the faeces, though smaller amounts are excreted in the urine and via lactation. (L177)
毒性值
LD50: 201 ug/kg (Oral, Rat) (T26) LD50: 120 ug/kg (Intraperitoneal, Mouse) (T14)
致死剂量
致癌性
1, carcinogenic to humans. (L135)
用途/来源
Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)
最低风险等级
Acute Oral: 0.0002 ug/kg/day (L134) Intermediate Oral: 0.00002 ug/kg/day (L134) Chronic Oral: 0.000001 ug/kg/day (L134)
健康影响
Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathologies, thyroid disorders, endometriosis, and diabetes. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is also a known as a human carcinogen. (L177, L178)
症状
In addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (L177)
治疗
Treatment of CDD exposure may include washing the area of contact, different methods of gastrointestinal decontamination, administration of intravenous fluids, or forced alkaline diuresis. (L346)
药库 ID
HMDB_ID
PubChem 化合物 ID
15625
维基百科链接
创建于
2009-03-06 18:58:02 UTC
更新于
2014-12-24 20:21:02 UTC

最新招商产品更多>>

免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:国家药品监督管理局| 国家中医药管理局| SDA药品评审中心| 医加医疗器械| 膏药生产厂家| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:33068302000535
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3